Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

INTRODUCTION: Sclerostin levels have been reported to be low in ankylosing spondylitis (AS), but there is no data regarding the possible role of this Wnt inhibitor during anti-tumor necrosis factor (TNF) therapy. The present study longitudinally evaluated sclerostin levels, inflammatory markers and...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Carla GS, Ribeiro, Ana CM, Moraes, Julio CB, Takayama, Liliam, Goncalves, Celio R, Rodrigues, Marcelo B, de Oliveira, Ricardo M, Silva, Clovis A, Bonfa, Eloisa, Pereira, Rosa MR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580528/
https://www.ncbi.nlm.nih.gov/pubmed/23062122
http://dx.doi.org/10.1186/ar4055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580528/
https://www.ncbi.nlm.nih.gov/pubmed/23062122
http://dx.doi.org/10.1186/ar4055

Ejemplares similares